Trump unofficially taps CMS chief Oz to spearhead ‘most favored nation’ talksnews2025-05-23T17:23:27+00:00May 23rd, 2025|Endpoints News|
US warns drugmakers against misrepresenting cost of imported productsnews2025-05-23T17:13:27+00:00May 23rd, 2025|Endpoints News|
CHMP clears path for GSK’s Blenrep relaunch, recommends four other drugs news2025-05-23T14:53:51+00:00May 23rd, 2025|Endpoints News|
Gilead notches another Phase 3 win for Trodelvy in triple-negative breast cancernews2025-05-23T12:30:20+00:00May 23rd, 2025|Endpoints News|
GSK’s Nucala wins COPD approval, stoking rivalry with Dupixent news2025-05-22T21:07:07+00:00May 22nd, 2025|Endpoints News|
#ASCO25: Roche confirms OS benefit for PI3K inhibitor Itovebi in breast cancernews2025-05-22T21:00:30+00:00May 22nd, 2025|Endpoints News|
#ASCO25: Jazz outlines full survival data for lung cancer drug Zepzelcanews2025-05-22T21:00:21+00:00May 22nd, 2025|Endpoints News|
House passes Trump tax bill with PBM and orphan drug reforms includednews2025-05-22T19:37:52+00:00May 22nd, 2025|Endpoints News|
Cigna, Novo Nordisk offer lower GLP-1 pricesnews2025-05-22T17:14:01+00:00May 22nd, 2025|Endpoints News|
The ‘MAHA report’: What it says about vaccines, medicine and the pharma industrynews2025-05-22T16:14:42+00:00May 22nd, 2025|Endpoints News|
